Searched for
INDIA PHARMA 2017
India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Why market rose today? Sensex rises 790 points, Nifty closes near 23,700. 5 key drivers behind surgeIndian stock markets are experiencing a significant rally. The BSE Sensex and Nifty 50 indices have climbed over 1 percent each. This surge...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- 74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
- Cutting China ties not easy, drug imports up 28% since DoklamThe country’s imports of pharmaceutical products from China, however, rose to ₹1,150 crore in 2019-20 from ₹947 crore in 2015-16, a cumulat...
- India wants China to allow import of drugs cleared by US, EuropeAlmost 1,500 Indian products have obtained clearances from the food and pharmaceutical regulators of the US, EU and Japan, but only 535 are...
- Sun Pharma shares rally after USFDA reclassifies Halol Unit as 'No Action Initiated'USFDA no action initiated status means clearance for the unit.
- Sun Pharma expects normalisation of India business in FY'19Sun Pharma MD Dilip Shanghvi said the government's enforced price cuts and policy changes are potential risk factors for the business.
- Pharma exports can cross $20 bn by 2020: Chief of PharmexcilIndia’s pharma exports grew 2.91% to $17.27 billion in 2017-18, according to the council.
- IndusInd Bank, Yes Bank to be part of BSE Sensex from Dec 18; Cipla, Lupin droppedIn BSE 100 index stocks of Federal Bank, Grasim, Vakrangee and Bajaj Holdings will be added.
- Pharma stocks in demand as market looks for safetyAnalysts now find the risk-reward attractive for large-cap quality pharma stocks.
- AstraZeneca gets extension for Meronem withdrawal till August 31The product is currently one of the company's principal products which generated 18 per cent total turnover of the firm in fiscal ended Mar...
- AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...
- AstraZeneca Pharma India Q4 net loss at Rs 2.87 croreThe company's total income from operations stood at Rs 111.57 crore for the quarter under consideration. It was Rs 158.82 crore for the sam...
- Government removes duty anomalies to boost medical devices mfg: Ananth KumarKumar assured the industry a transparent and predictable drug price regime and called upon the companies to provide quality drugs at afford...
- Sun Pharma appoints Abhay Gandhi CEO of North American businessSun Pharma today announced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North America...
- India slips in rankings as slowdown hits pharmaConventional wisdom suggests that healthcare sector is recession proof and does not necessarily mirror the lows and highs of the economy.
Load More
